Global /South Korea /Healthcare /Drug Manufacturers - General /053950

Kyung Nam Pharm Co.,Ltd.

053950

• KRX: 053950 • Delayed

3,845KRW -0.4%

2.53 USD

As of 15 June 2026, Kyung Nam Pharm Co.,Ltd. has a market cap of $39.52M USD, ranking #32254 globally and #1906 in South Korea. It ranks #2919 in the Healthcare sector, and #1009 in the Drug Manufacturers - General industry.

Global Rank

32254

Country Rank

1906

Sector Rank

2919

Industry Rank

1009

Key Stats

Market Cap

$39.52MUSD

60.1B KRW

Enterprise Value

$33.85MUSD

51.39B KRW

Revenue (TTM)

$36.94MUSD

56.18B KRW

EBITDA (TTM)

$1.76MUSD

2.67B KRW

Net Income (TTM)

$6.32MUSD

9.61B KRW

EBITDA Margin

4.8%

Profit Margin

17%

PE Ratio

6.3

PS Ratio

1.1

PB Ratio

0.5

EV/EBITDA

18.9

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Oh Hwan open_in_new

Employees

243

Founded

1993

Website

kyungnampharm.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	-2%	15%	20%	31%	13%	20%	-57%	-89%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	053950 경남제약 주식회사 ISIN: KR7053950002 Shares Out.: Shares Outstanding: 15.629M¹ Shares Float: 8.477M² TV: TradingView: KRX: 053950 SA: Stock Analysis: KRX: 053950 YF: Yahoo Finance: 053950.KS GF: Google Finance: KRX: 053950 BA: Barron's: 053950 MS: Morningstar: XKRX: 053950	3,845 KRW	TV: TradingView: KRX: 053950 SA: Stock Analysis: KRX: 053950 YF: Yahoo Finance: 053950.KS GF: Google Finance: KRX: 053950 BA: Barron's: 053950 MS: Morningstar: XKRX: 053950

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kyung Nam Pharm Co.,Ltd.

Kyung Nam Pharm Co.,Ltd. engages in the manufacture and sale of pharmaceutical, cosmetic, chemical, and health functional food products in South Korea, North America, and rest of Asia. It also offers electronic, and agricultural and livestock products. The company was formerly known as HS Bio Pharm Co., Ltd. and changed its name to Kyung Nam Pharm Co.,Ltd. in May 2010. Kyung Nam Pharm Co.,Ltd. was founded in 1993 and is headquartered in Uiryeong-eup, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 23K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 17K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 13K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 12K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 11K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 11K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 1M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 913K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 814K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 731K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 695K%	20.5	Switzerland

chevron_leftBack